Alexander Roussanov
EMA launches new version of EudraCT
Focus on Regulation ·
EMA releases a draft revision to the Biosimilars Guideline for public consultation
Biosimilars Law Blog ·
EMA takes steps toward facilitating global clinical trials for biosimilars
Biosimilars Law Blog ·